June Sherie Almenoff, Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI), bought 1,475 shares at $3.39 ($5K) on 2019-01-04, disclosed to the SEC on 2019-01-08.
Open-market purchase of $5k BCLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| INNT | BUY | 2018-08-28 | $7K | — | Filing → |
| OHRP | BUY | 2015-02-10 | $41K | — | Filing → |
| OHRP | BUY | 2014-06-30 | $27K | — | Filing → |